Key result
Molecular genetic investigations of primary cardiac tumors have identified specific gene mutations, such as PRKAR1alpha in myxomas and TSC genes in rhabdomyomas, regulating cardiac cell growth.
Understanding the molecular genetics of primary cardiac tumors may provide insights into fundamental mechanisms of cardiac cell growth and potential strategies for myocardial regeneration.
Findings remain preliminary for clinical use; leaves open genetic targets for myocardial regeneration research.
Recent molecular genetic investigations of primary cardiac tumors (myxomas, lipomas, rhabdomyomas, and fibromas) have provided insight into fundamental mechanisms of cardiac cell growth. Myxomas are the most common adult cardiac tumor, and familial cardiac myxomas are now appreciated to be caused by mutations in the PRKAR1alpha gene that encodes a regulatory subunit of protein kinase A. Cytogenetic studies have targeted candidate chromosomal loci that may be perturbed during cardiac lipoma pathogenesis. Rhabdomyomas, the most common pediatric cardiac neoplasm, are frequently associated with tuberous sclerosis, caused by mutations in the TSC-1 and TSC-2 genes. The study of Gorlin syndrome has shed light on the etiology of cardiac fibromas. This disorder is caused by mutation of the PTC gene, which regulates cell growth, commitment and differentiation. In the future, manipulation of PRKAR1alpha-, TSC-, and PTC-dependent pathways may foster new strategies to regenerate myocardium in the ischemic or myopathic heart.
No takes yet. Share an insight, caveat, or question.
Vaughan et al. (2001) conducted a review in Primary cardiac tumors. Molecular genetic investigations of primary cardiac tumors have identified specific gene mutations, such as PRKAR1alpha in myxomas and TSC genes in rhabdomyomas, regulating cardiac cell growth.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: